Clinical Trial: The relationship between two different nutritional assessment tools (Japan)

Tokyo, Jan. 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060278) titled 'A prospective study examining the association between two different nutritional assessment tools' on Jan. 7. Study Type: Observational Primary Sponsor: Institute - Kansai Electric Power Medical Research Institute Condition: Condition - Adult patients admitted to acute care hospitals Classification by malignancy - Others Genomic information - NO Objective: Narrative obj...


Clinical Trial: Effect of food-containing ingredients on increasing lipid consumption at rest (Japan)

Tokyo, Jan. 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060072) titled 'Effect of food-containing ingredients on increasing lipid consumption at rest' on Jan. 7. Study Type: Interventional Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Double blind -all involved are blinded Control - Placebo Primary Sponsor: Institute - Suntory beverage & Food limited. Condition: Condition - Not applicable Classification by mal...


Clinical Trial: The comparison of the pharmacokinetics between various formulations containing Brazilian green propolis in healthy volunteers (Japan)

Tokyo, Jan. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060214) titled 'The comparison of the pharmacokinetics between various formulations containing Brazilian green propolis in healthy volunteers' on Jan. 6. Study Type: Interventional Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Historical Primary Sponsor: Institute - Yamada Bee Company, Inc. Condition: Condition - Ad...


Clinical Trial: The inhibitory effect of NVIF2025-02 intake on diarrhea symptoms (Japan)

Tokyo, Jan. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060172) titled 'The inhibitory effect of NVIF2025-02 intake on diarrhea symptoms' on Jan. 6. Study Type: Interventional Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Uncontrolled Primary Sponsor: Institute - Mejiro Daini Hospital, Etsudenkai Medical Corporation Condition: Condition - Patients receiving enteral nutri...


Clinical Trial: Clarification of changes in plasma concentration and protein binding rate of remimazolam when co-administered with propofol (Japan)

Tokyo, Jan. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060266) titled 'Changes in blood concentration and protein binding of the benzodiazepine sedative remimazolam during co-administration with the general anesthetic propofol' on Jan. 6. Study Type: Interventional Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Self control Primary Sponsor: Institute - Hamamatsu Universit...


Clinical Trial: The diagnostic accuracy of large language models in screening citations in orthopaedic literatures (Japan)

Tokyo, Jan. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060250) titled 'The diagnostic accuracy of large language models in screening citations in orthopaedic literatures' on Jan. 6. Study Type: Observational Primary Sponsor: Institute - Teikyo University Condition: Condition - the musculoskeletal literature Classification by malignancy - Others Genomic information - NO Objective: Narrative objectives1 - This study aims to elucidate the di...


Clinical Trial: Elucidation of Changes in Plasma Concentration and Protein Binding Ratio of Propofol during Co-administration with Remimazolam (Japan)

Tokyo, Jan. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060265) titled 'Elucidation of Changes in Plasma Concentration and Protein Binding Ratio of Propofol during Co-administration with Remimazolam' on Jan. 6. Study Type: Interventional Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Self control Primary Sponsor: Institute - Hamamatsu University School of Medicine Conditi...


Clinical Trial: A Study of High Stress Classification and Associated Factors among Workers with Neurodevelopmental Traits (Japan)

Tokyo, Jan. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060243) titled 'A Study of High Stress Classification and Associated Factors among Workers with Neurodevelopmental Traits' on Jan. 6. Study Type: Others,meta-analysis etc Primary Sponsor: Institute - Kwansei Gakuin University Condition: Condition - Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder Classification by malignancy - Others Genomic information - NO Objec...


Clinical Trial: Usability evaluation of a microlearning app for people with chronic kidney disease (Japan)

Tokyo, Jan. 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060272) titled 'Usability evaluation of a microlearning app for people with chronic kidney disease' on Jan. 6. Study Type: Interventional Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Self control Primary Sponsor: Institute - Gunma University Condition: Condition - Chronic kidney disease Classification by malignancy...


Clinical Trial: An Open-Label, Single-Arm Phase II Study of Enfortumab Vedotin Plus Pembrolizumab in Patients with Unresectable Urothelial Carcinoma (Japan)

Tokyo, Jan. 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060270) titled 'An Open-Label, Single-Arm Phase II Study of Enfortumab Vedotin Plus Pembrolizumab in Patients with Unresectable Urothelial Carcinoma' on Jan. 6. Study Type: Interventional Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Historical Primary Sponsor: Institute - Kanazawa University Condition: Condition - ...